To investigate whether the role of ADAM9 for promoting the plasminogen activator-based pathway is clinically relevant, we measured the correlation of ADAM9 and PLAT or SERPINE1 expression in ESCC specimens from The Cancer Genome Atlas (TCGA) dataset. Here, ADAM9 is linked to esophageal squamous cell carcinoma.